These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 1933859

  • 1. Importance of transforming growth factor alpha/epidermal growth factor receptor autocrine growth mechanism in an ovarian cancer cell line in vivo.
    Kurachi H, Morishige K, Amemiya K, Adachi H, Hirota K, Miyake A, Tanizawa O.
    Cancer Res; 1991 Nov 01; 51(21):5956-9. PubMed ID: 1933859
    [Abstract] [Full Text] [Related]

  • 2. Involvement of transforming growth factor alpha/epidermal growth factor receptor autocrine growth mechanism in an ovarian cancer cell line in vitro.
    Morishige K, Kurachi H, Amemiya K, Adachi H, Inoue M, Miyake A, Tanizawa O, Sakoyama Y.
    Cancer Res; 1991 Nov 01; 51(21):5951-5. PubMed ID: 1718591
    [Abstract] [Full Text] [Related]

  • 3. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.
    Fan Z, Masui H, Altas I, Mendelsohn J.
    Cancer Res; 1993 Sep 15; 53(18):4322-8. PubMed ID: 8364927
    [Abstract] [Full Text] [Related]

  • 4. Evidence for the involvement of transforming growth factor alpha and epidermal growth factor receptor autocrine growth mechanism in primary human ovarian cancers in vitro.
    Morishige K, Kurachi H, Amemiya K, Fujita Y, Yamamoto T, Miyake A, Tanizawa O.
    Cancer Res; 1991 Oct 01; 51(19):5322-8. PubMed ID: 1717146
    [Abstract] [Full Text] [Related]

  • 5. Transforming growth factor-alpha acts as an autocrine growth factor in ovarian carcinoma cell lines.
    Stromberg K, Collins TJ, Gordon AW, Jackson CL, Johnson GR.
    Cancer Res; 1992 Jan 15; 52(2):341-7. PubMed ID: 1309440
    [Abstract] [Full Text] [Related]

  • 6. Autocrine transforming growth factor alpha is dispensible for v-rasHa-induced epidermal neoplasia: potential involvement of alternate epidermal growth factor receptor ligands.
    Dlugosz AA, Cheng C, Williams EK, Darwiche N, Dempsey PJ, Mann B, Dunn AR, Coffey RJ, Yuspa SH.
    Cancer Res; 1995 May 01; 55(9):1883-93. PubMed ID: 7728756
    [Abstract] [Full Text] [Related]

  • 7. Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells.
    Ciardiello F, Bianco R, Damiano V, Fontanini G, Caputo R, Pomatico G, De Placido S, Bianco AR, Mendelsohn J, Tortora G.
    Clin Cancer Res; 2000 Sep 01; 6(9):3739-47. PubMed ID: 10999768
    [Abstract] [Full Text] [Related]

  • 8. Involvement of transforming growth factor-alpha and its receptor in the growth response of cultured human epidermal cells to retinoic acid.
    Piazza GA, Ritter JL.
    Epithelial Cell Biol; 1993 Oct 01; 2(4):170-5. PubMed ID: 8269032
    [Abstract] [Full Text] [Related]

  • 9. Inhibitory effect of anti-epidermal growth factor receptor antibody on a human gastric cancer.
    Teramoto T, Onda M, Tokunaga A, Asano G.
    Cancer; 1996 Apr 15; 77(8 Suppl):1639-45. PubMed ID: 8608556
    [Abstract] [Full Text] [Related]

  • 10. Epidermal growth factor receptors in human breast carcinoma cells: a potential selective target for transforming growth factor alpha-Pseudomonas exotoxin 40 fusion protein.
    Arteaga CL, Hurd SD, Dugger TC, Winnier AR, Robertson JB.
    Cancer Res; 1994 Sep 01; 54(17):4703-9. PubMed ID: 8062268
    [Abstract] [Full Text] [Related]

  • 11. Epidermal growth factor receptor-mediated autocrine and paracrine stimulation of human transitional cell carcinoma.
    Gleave ME, Hsieh JT, Wu HC, Hong SJ, Zhau HE, Guthrie PD, Chung LW.
    Cancer Res; 1993 Nov 01; 53(21):5300-7. PubMed ID: 8221665
    [Abstract] [Full Text] [Related]

  • 12. Transforming growth factor-alpha promotes tumor markers secretion from human ovarian cancers in vitro.
    Kurachi H, Adachi H, Morishige K, Adachi K, Takeda T, Homma H, Yamamoto T, Miyake A.
    Cancer; 1996 Sep 01; 78(5):1049-54. PubMed ID: 8780543
    [Abstract] [Full Text] [Related]

  • 13. Abrogation of transforming growth factor-alpha/epidermal growth factor receptor autocrine signaling by an RXR-selective retinoid (LGD1069, Targretin) in head and neck cancer cell lines.
    Song JI, Lango MN, Hwang JD, Drenning SD, Zeng Q, Lamph WW, Grandis JR.
    Cancer Res; 2001 Aug 01; 61(15):5919-25. PubMed ID: 11479234
    [Abstract] [Full Text] [Related]

  • 14. Significance of tyrosine kinase activity on malign transformation of ovarian tumors: a comparison between EGF-R and TGF-alpha.
    Zeren T, Inan S, Seda Vatansever H, Ekerbicer N, Sayhan S.
    Acta Histochem; 2008 Aug 01; 110(3):256-63. PubMed ID: 18054376
    [Abstract] [Full Text] [Related]

  • 15. Tumorigenic transformation of NIH 3T3 cells by the autocrine synthesis of transforming growth factor alpha.
    Ju WD, Velu TJ, Vass WC, Papageorge AG, Lowy DR.
    New Biol; 1991 Apr 01; 3(4):380-8. PubMed ID: 2065023
    [Abstract] [Full Text] [Related]

  • 16. Differential dependence of the tumorigenicity of chemically transformed rat liver epithelial cells on autocrine production of transforming growth factor alpha.
    Duddy SK, Earp HS, Russell WE, Smith GJ, Grisham JW.
    Cell Growth Differ; 1995 Mar 01; 6(3):251-61. PubMed ID: 7794793
    [Abstract] [Full Text] [Related]

  • 17. Regulation of autocrine gastrin expression by the TGF alpha autocrine loop.
    Howell GM, Ziober BL, Humphrey LE, Willson JK, Sun L, Lynch M, Brattain MG.
    J Cell Physiol; 1995 Feb 01; 162(2):256-65. PubMed ID: 7822434
    [Abstract] [Full Text] [Related]

  • 18. Expression of human transforming growth factor alpha by Chinese hamster ovarian tumors in nude mice causes hypercalcemia and increased osteoclastic bone resorption.
    Yates AJ, Boyce BF, Favarato G, Aufdemorte TB, Marcelli C, Kester MB, Walker R, Langton BC, Bonewald LF, Mundy GR.
    J Bone Miner Res; 1992 Jul 01; 7(7):847-53. PubMed ID: 1642153
    [Abstract] [Full Text] [Related]

  • 19. Monoclonal antibody 425 inhibits growth stimulation of carcinoma cells by exogenous EGF and tumor-derived EGF/TGF-alpha.
    Rodeck U, Williams N, Murthy U, Herlyn M.
    J Cell Biochem; 1990 Oct 01; 44(2):69-79. PubMed ID: 2250044
    [Abstract] [Full Text] [Related]

  • 20. Antitumor activity of anti-epidermal growth factor receptor monoclonal antibodies and cisplatin in ten human head and neck squamous cell carcinoma lines.
    Hoffmann T, Hafner D, Ballo H, Haas I, Bier H.
    Anticancer Res; 1997 Oct 01; 17(6D):4419-25. PubMed ID: 9494544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.